InvestorsHub Logo
Followers 270
Posts 15407
Boards Moderated 1
Alias Born 03/28/2013

Re: None

Thursday, 05/10/2018 12:45:52 PM

Thursday, May 10, 2018 12:45:52 PM

Post# of 2029
The Phase 3 U.S. study is a multicenter, randomized, double-blind, placebo-controlled 12-week treatment trial (with a 52-week open label extension phase) in the U.S. designed to evaluate the safety and efficacy of 0.5 mcg/kg of KORSUVA injection in 350 hemodialysis patients with moderate-to-severe pruritus.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CARA News